| DNA Binding Studies of Novel Copper(II) Complexes Containing l-Tryptophan as Chiral Auxiliary: In Vitro Antitumor Activity of Cu−Sn2 Complex in Human … M Chauhan, K Banerjee, F Arjmand Inorganic chemistry 46 (8), 3072-3082, 2007 | 279 | 2007 |
| Synthesis, antibacterial, antifungal activity and interaction of CT-DNA with a new benzimidazole derived Cu (II) complex F Arjmand, B Mohani, S Ahmad European journal of medicinal chemistry 40 (11), 1103-1110, 2005 | 253 | 2005 |
| Synthesis and characterization of dinuclear macrocyclic cobalt (II), copper (II) and zinc (II) complexes derived from 2, 2, 2′, 2′-S, S [bis (bis-N, N-2 … F Arjmand, M Aziz European journal of medicinal chemistry 44 (2), 834-844, 2009 | 210 | 2009 |
| Synthesis, characterization and interaction studies of copper based drug with human serum albumin (HSA): spectroscopic and molecular docking investigations S Tabassum, WM Al-Asbahy, M Afzal, F Arjmand Journal of Photochemistry and Photobiology B: Biology 114, 132-139, 2012 | 183 | 2012 |
| Synthesis of new chiral heterocyclic Schiff base modulated Cu (II)/Zn (II) complexes: their comparative binding studies with CT-DNA, mononucleotides and cleavage activity F Arjmand, F Sayeed, M Muddassir Journal of Photochemistry and Photobiology B: Biology 103 (2), 166-179, 2011 | 163 | 2011 |
| Mixed-ligand Cu (II)–vanillin Schiff base complexes; effect of coligands on their DNA binding, DNA cleavage, SOD mimetic and anticancer activity S Tabassum, S Amir, F Arjmand, C Pettinari, F Marchetti, N Masciocchi, ... European Journal of Medicinal Chemistry 60, 216-232, 2013 | 146 | 2013 |
| Synthesis, characterization, biological studies (DNA binding, cleavage, antibacterial and topoisomerase I) and molecular docking of copper (II) benzimidazole complexes F Arjmand, S Parveen, M Afzal, M Shahid Journal of Photochemistry and Photobiology B: Biology 114, 15-26, 2012 | 143 | 2012 |
| Interaction and photo-induced cleavage studies of a copper based chemotherapeutic drug with human serum albumin: spectroscopic and molecular docking study S Tabassum, WM Al-Asbahy, M Afzal, F Arjmand, RH Khan Molecular BioSystems 8 (9), 2424-2433, 2012 | 124 | 2012 |
| Synthesis and characterization of copper (II) and zinc (II)-based potential chemotherapeutic compounds: their biological evaluation viz. DNA binding profile, cleavage and … S Tabassum, A Asim, F Arjmand, M Afzal, V Bagchi European journal of medicinal chemistry 58, 308-316, 2012 | 123 | 2012 |
| Organo-tin antitumor compounds: Their present status in drug development and future perspectives F Arjmand, S Parveen, S Tabassum, C Pettinari Inorganica Chimica Acta 423, 26-37, 2014 | 118 | 2014 |
| Chiral preference of l-tryptophan derived metal-based antitumor agent of late 3d-metal ions (Co (II), Cu (II) and Zn (II)) in comparison to d-and dl-tryptophan analogues: Their … F Arjmand, M Muddassir, RH Khan European journal of medicinal chemistry 45 (9), 3549-3557, 2010 | 99 | 2010 |
| Current and future potential of metallo drugs: Revisiting DNA-binding of metal containing molecules and their diverse mechanism of action M Zaki, F Arjmand, S Tabassum Inorganica Chimica Acta 444, 1-22, 2016 | 90 | 2016 |
| Mechanistic insights into a novel chromone-appended Cu (II) anticancer drug entity: in vitro binding profile with DNA/RNA substrates and cytotoxic activity against MCF-7 and … I Yousuf, F Arjmand, S Tabassum, L Toupet, RA Khan, MA Siddiqui Dalton Transactions 44 (22), 10330-10342, 2015 | 89 | 2015 |
| New modulated design and synthesis of quercetin–Cu II/Zn II–Sn 2 IV scaffold as anticancer agents: in vitro DNA binding profile, DNA cleavage pathway and Topo-I activity S Tabassum, M Zaki, M Afzal, F Arjmand Dalton Transactions 42 (27), 10029-10041, 2013 | 87 | 2013 |
| Molecular drug design, synthesis and crystal structure determination of CuII–SnIV heterobimetallic core: DNA binding and cleavage studies F Arjmand, S Parveen, M Afzal, L Toupet, TB Hadda European Journal of Medicinal Chemistry 49, 141-150, 2012 | 82 | 2012 |
| Molecular drug design, synthesis and structure elucidation of a new specific target peptide based metallo drug for cancer chemotherapy as topoisomerase I inhibitor S Tabassum, WM Al-Asbahy, M Afzal, F Arjmand, V Bagchi Dalton Transactions 41 (16), 4955-4964, 2012 | 81 | 2012 |
| DNA binding studies of new valine derived chiral complexes of tin (IV) and zirconium (IV) F Arjmand, A Jamsheera Spectrochimica acta part A: molecular and biomolecular spectroscopy 78 (1 …, 2011 | 74 | 2011 |
| Enantiomeric amino acid schiff base copper (II) complexes as a new class of RNA-targeted metallo-intercalators: Single X-ray crystal structural details, comparative in vitro … S Zehra, T Roisnel, F Arjmand ACS Omega 4 (4), 7691-7705, 2019 | 68 | 2019 |
| Synthesis and spectroscopic characterization of diorganotin (IV) complexes of N′-(4-hydroxypent-3-en-2-ylidene) isonicotinohydrazide: chemotherapeutic potential validation by … S Yadav, I Yousuf, M Usman, M Ahmad, F Arjmand, S Tabassum RSC Advances 5 (63), 50673-50690, 2015 | 67 | 2015 |
| New modulated metallic macrocycles: electrochemistry and their interaction with calf thymus DNA S Tabassum, S Parveen, F Arjmand Acta Biomaterialia 1 (6), 677-689, 2005 | 66 | 2005 |
Prof. Sartaj TabassumDepartment of Chemistry,Aligarh Muslim UniversityVerified email at amu.ac.in
